Previous close | 375.15 |
Open | 380.00 |
Bid | 388.89 x 800 |
Ask | 389.40 x 800 |
Day's range | 377.14 - 392.07 |
52-week range | 310.42 - 415.73 |
Volume | |
Avg. volume | 534,512 |
Market cap | 28.565B |
Beta (5Y monthly) | 1.02 |
PE ratio (TTM) | 49.52 |
EPS (TTM) | 7.88 |
Earnings date | 25 Apr 2024 |
Forward dividend & yield | 0.80 (0.21%) |
Ex-dividend date | 23 Apr 2024 |
1y target est | 400.43 |
West Pharmaceutical's (WST) first-quarter 2024 results are likely to reflect strength in its Proprietary Products business. However, unfavorable currency movements might have hurt the top and bottom lines.
West Pharmaceutical (WST) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
West Pharmaceutical (WST) continues to gain momentum due to its strength in the Proprietary Products business. However, forex concerns persist.